Literature DB >> 12075222

A rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection: methods and disease course.

Otavio B Piltcher1, J Douglas Swarts, Karin Magnuson, Cuneyt M Alper, William J Doyle, Patricia A Hebda.   

Abstract

OBJECTIVE: To describe the clinical and histopathologic progression of a rat model of otitis media with effusion caused by eustachian tube obstruction (ETO) with and without Streptococcus pneumoniae infection.
METHODS: In 164 rats, the left, bony eustachian tube was approached via a ventral incision and obstructed with dental material. Then 108 rats were infected via an intrabullar injection with S pneumoniae. At 48 hours, the infected rats were treated for 5 days with ampicillin. All ears were evaluated by weekly otomicroscopy. On each of days 1, 2, 7, 21, 35, 56, and 112, four rats were killed for histologic study. All effusions were cultured for bacteria.
RESULTS: Fourteen rats died of surgical complications; effusion resolved by 2 weeks in 9 rats. During the first few days, infected ears with ETO had bulging tympanic membranes, followed by tympanic membrane retraction, purulent effusion, and otorrhea (50%) over the next few weeks, whereas uninfected ears with ETO developed retraction and serous effusion during the same time frame. At later times, all ears with ETO presented with retraction and serous or serous-mucoid effusion. S pneumoniae was recovered only from the infected ears with ETO (days 1 and 2), with some colonization by nonpathogenic microorganisms observed equally in both groups of ears. Histology showed a typical acute inflammatory reaction in the challenged ears with ETO through day 14 and then a chronic inflammation for all ears with ETO.
CONCLUSION: The experimental methods provoked reproducible pathologic signs similar to those for otitis media with effusion. Given the availability of rat-specific reagents, this model is well suited for studies of cytokine elaboration during disease pathogenesis.

Entities:  

Mesh:

Year:  2002        PMID: 12075222     DOI: 10.1067/mhn.2002.124935

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  14 in total

1.  Heparin binding-epidermal growth factor-like growth factor for the regeneration of chronic tympanic membrane perforations in mice.

Authors:  Peter Luke Santa Maria; Sungwoo Kim; Yasin Kursad Varsak; Yunzhi Peter Yang
Journal:  Tissue Eng Part A       Date:  2015-03-17       Impact factor: 3.845

2.  Novel rat model of tympanostomy tube otorrhea.

Authors:  Rodrigo C Silva; Joseph E Dohar; Patricia A Hebda
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2011-12-22       Impact factor: 1.675

3.  Novel method for non-invasive induction of a middle-ear biofilm in the rat.

Authors:  Eric J Chaney; Cac T Nguyen; Stephen A Boppart
Journal:  Vaccine       Date:  2011-01-04       Impact factor: 3.641

4.  A novel model of spontaneous otitis media with effusion (OME) in the Oxgr1 knock-out mouse.

Authors:  Joseph E Kerschner; Wenzhou Hong; Steven R Taylor; John A Kerschner; Pawjai Khampang; Kay C Wrege; Paula E North
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2012-11-30       Impact factor: 1.675

5.  Non-invasive optical interferometry for the assessment of biofilm growth in the middle ear.

Authors:  Cac T Nguyen; Haohua Tu; Eric J Chaney; Charles N Stewart; Stephen A Boppart
Journal:  Biomed Opt Express       Date:  2010-10-07       Impact factor: 3.732

Review 6.  Development of animal models of otitis media.

Authors:  Moo Kyun Park; Byung Don Lee
Journal:  Korean J Audiol       Date:  2013-04-16

7.  A model of chronic, transmissible Otitis Media in mice.

Authors:  Kalyan K Dewan; Dawn L Taylor-Mulneix; Laura L Campos; Amanda L Skarlupka; Shannon M Wagner; Valerie E Ryman; Monica C Gestal; Longhua Ma; Uriel Blas-Machado; Brian T Faddis; Eric T Harvill
Journal:  PLoS Pathog       Date:  2019-04-10       Impact factor: 6.823

8.  Treatment with a neutrophil elastase inhibitor and ofloxacin reduces P. aeruginosa burden in a mouse model of chronic suppurative otitis media.

Authors:  K M Khomtchouk; L I Joseph; B B Khomtchouk; A Kouhi; S Massa; A Xia; I Koliesnik; D Pletzer; P L Bollyky; P L Santa Maria
Journal:  NPJ Biofilms Microbiomes       Date:  2021-04-06       Impact factor: 7.290

Review 9.  From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children.

Authors:  Elena Lia Spoială; Gabriela Dumitrita Stanciu; Veronica Bild; Daniela Carmen Ababei; Cristina Gavrilovici
Journal:  Antibiotics (Basel)       Date:  2021-01-06

10.  Stenting the Eustachian tube to treat chronic otitis media - a feasibility study in sheep.

Authors:  Friederike Pohl; Robert A Schuon; Felicitas Miller; Andreas Kampmann; Eva Bültmann; Christian Hartmann; Thomas Lenarz; Gerrit Paasche
Journal:  Head Face Med       Date:  2018-05-04       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.